Genetic determinants associated with early age of diagnosis of IBD

Diseases of the Colon and Rectum

Volumn 58, Issue 3, 2015, Pages 321-327

  Connelly, Tara M ^a   Berg, Arthur S ^a   Iii, Leonard Harris ^a   Brinton, David ^a   Deiling, Sue ^a   Koltun, Walter A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Crohn's disease; LAMB1; NOD2; POU5F1; Surgical genetics; Ulcerative colitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; HLA DRB1 ANTIGEN; LAMININ 1; OCTAMER TRANSCRIPTION FACTOR 4; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; LAMB1 PROTEIN, HUMAN; LAMININ; NOD2 PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN; TNFSF15 PROTEIN, HUMAN;

ADOLESCENT; ADULT; CONFERENCE PAPER; CROHN DISEASE; GENETIC ASSOCIATION; GENETIC COUNSELING; GENOTYPE; GROUPS BY AGE; HETEROZYGOTE; HLA SYSTEM; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; ONSET AGE; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; UNITED STATES;

ADOLESCENT; ADULT; AGE OF ONSET; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DRB1 CHAINS; HUMANS; LAMININ; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; OCTAMER TRANSCRIPTION FACTOR-3; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; UNITED STATES;

EID: 84928111661     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000274     Document Type: Conference Paper

References (27)

1. Rose JD, Roberts GM, Williams G, Mayberry JF, Rhodes J. Cardiff Crohn's disease jubilee: The incidence over 50 years. Gut. 1988;29:346-351.
2. Polito JM 2nd, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: Influence of age at diagnosis on site and clinical type of disease. Gastroenterology. 1996;111:580-586.
3. Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum-is it the same disease? Nat Rev Gastroenterol Hepatol. 2014;11:88-98.
4. Amoli MM, Carthy D, Platt H, Ollier WE. EBV Immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood. Int J Epidemiol. 2008;37(suppl 1):41-45.
5. Parkes M, Barrett JC, Prescott NJ, et al.; Wellcome Trust Case Control Consortium. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007;39:830-832.
6. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603.
7. McCauley JL, Abreu MT. Genetics in diagnosing and managing inflammatory bowel disease. Gastroenterol Clin North Am. 2012;41:513-522.
8. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066-2078.
9. Kosovac K, Brenmoehl J, Holler E, et al. Association of the NOD2 genotype with bacterial translocation via altered cellcell contacts in Crohn's disease patients. Inflamm Bowel Dis. 2010;16:1311-1321.
10. Bonen DK, Ogura Y, Nicolae DL, et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology. 2003;124:140-146.
11. Gazouli M, Pachoula I, Panayotou I, et al. NOD2/CARD15, AT - G16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease. World J Gastroenterol. 2010;16:1753-1758.
12. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology. 2002;122:854-866.
13. Büning C, Genschel J, Bühner S, et al. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther. 2004;19:1073-1078.
14. Maconi G, Colombo E, Sampietro GM, et al. CARD15 gene variants and risk of reoperation in Crohn's disease patients. Am J Gastroenterol. 2009;104:2483-2491.
15. Zhu KJ, Lv YM, Yin XY, et al. Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo. PLoS One. 2011;6:23089.
16. Génin E, Schumacher M, Roujeau JC, et al. Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe. Orphanet J Rare Dis. 2011;6:52.
17. Yasuda H, Tanaka K, Okita Y, et al. CD133, OCT4, and NANO G in ulcerative colitis-associated colorectal cancer. Oncol Lett. 2011;2:1065-1071.
18. Edwards TL, Shrubsole MJ, Cai Q, et al. Genome-wide association study identifies possible genetic risk factors for colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2013;22:1219-1226.
19. Yang CR, Hsieh SL, Teng CM, Ho FM, Su WL, Lin WW. Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action. Cancer Res. 2004;64:1122-1129.
20. Plevy SE, Targan SR. Future therapeutic approaches for inflammatory bowel diseases. Gastroenterology. 2011;140:1838-1846.
21. Bamias G, Martin C 3rd, Marini M, et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol. 2003;171:4868-4874.
22. Michelsen KS, Thomas LS, Taylor KD, et al. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS One. 2009;4:4719.
23. Haritunians T, Taylor KD, Targan SR, et al. Genetic predictors of medically refractory ulcerative colitis. Inflamm Bowel Dis. 2010;16:1830-1840.
24. Barrett JC, Lee JC, Lees CW, et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet. 2009;41:1330-1334.
25. Schmehl K, Florian S, Jacobasch G, Salomon A, Körber J. Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa. Int J Colorectal Dis. 2000;15:39-48.
26. Imielinski M, Baldassano RN, Griffiths A, et al.; Western Regional Alliance for Pediatric IBD; International IBD Genetics Consortium; NIDDK IBD Genetics Consortium; Belgian-French IBD Consortium; Wellcome Trust Case Control Consortium. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet. 2009;41:1335-1340.
27. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361:2033-2045.